Skip to content
Use caution Drug recall · FDA · Published August 31, 2026

TerSera Recalls Zoladex Implants Due to Temperature Abuse

TerSera Therapeutics recalls 296 cartons of Zoladex 3.6 mg implants because they were exposed to uncontrolled temperatures during shipping.

🇺🇸 FDA recall #D-0875-2026DrugTerSera ›
✎ GovInfoNow plain-language explainer

TerSera Therapeutics LLC is recalling a small batch of Zoladex (goserelin) implants, specifically the 3.6 mg single-use syringe packaged in a carton. The recall was initiated because the product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours. This exposure to temperature abuse may compromise the integrity of the medication. Read more at govinfonow.com/recall/1443852-tersera-therapeutics-llc-recalls-zoladex-goserelin-implant-3-6-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/1443852-tersera-therapeutics-llc-recalls-zoladex-goserelin-implant-3-6-mg · Updated October 13, 2026 · FDA enforcement record: FDA #D-0875-2026

Cite this page

“TerSera Recalls Zoladex Implants Due to Temperature Abuse.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/1443852-tersera-therapeutics-llc-recalls-zoladex-goserelin-implant-3-6-mg. Based on FDA recall #D-0875-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0875-2026%22&limit=1).

The FDA announced on Aug. 31, 2026, that TerSera Therapeutics LLC is recalling Zoladex (goserelin) implants due to temperature abuse risks. The recall affects 296 cartons distributed nationwide.

How to tell if you have it

  • Brand: TerSera
  • Product: Zoladex Implant 3.6 mg
  • Lot code: YN0099
  • Expiration date: 01/31/2028
  • NDC: 70720-950-36

The hazard

The product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours, according to the FDA.

Context

GovInfoNow's records show other recent recalls of similar products include McKesson Recalls UDENYCA Injection Due to Temperature Abuse Risk (2026-01-16) and McKesson Gemcitabine Injection Recall: Temperature Storage Risk (2026-06-10). Teva Clonidine Transdermal System Recall: Unapproved Raw Material Risk occurred on 2026-03-19.

How to tell if you have this one

Check your medication carton for the brand Zoladex, the strength 3.6 mg, and the NDC 70720-950-36. Verify that the lot number is YN0099 and the expiration date is 01/31/2028.

  • Brand
    TerSera
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Medication

    Verify if your Zoladex carton matches lot YN0099 and expiration date 01/31/2028.

  2. Contact Your Healthcare Provider

    Speak with your doctor or pharmacist about whether you should use the product or obtain a replacement, as the remedy is not explicitly stated in the record.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 37 days after the firm started it.

1. Firm started the recall: Aug 31, 202612. FDA classified it Class II: Sep 28, 202623. Published in FDA’s Enforcement Report: Oct 7, 202634. Added to GovInfoNow: Oct 13, 202642026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0875-2026 (August 31, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0875-2026 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA